Public Health Emergency - Leading a Nation Prepared
Weekly reporting on the use of federally purchased COVID-19 therapeutics is required each Wednesday by 11:59 pm ET. Sites that administer these therapies must provide information regarding product utilization and stock on hand to the U.S. Department of Health and Human Services through HHS Protect, TeleTracking, CDC’s National Healthcare Safety Network (NHSN), or through state/territory health departments, depending on facility type and jurisdictional guidance.
All sites administering federally purchased COVID-19 therapeutics must report required information each week. These sites include:
For sites reporting COVID-19 monoclonal antibody utilization information for the first time sites, report quantity of mAb therapies on hand and the amount of product used TO DATE since the facility began receiving mAbs. This guidance only applies to the first week of reporting, and all subsequent reports must be based on weekly utilization.
Home | Contact Us | Accessibility | Privacy Policies | Disclaimer | HHS Viewers & Players | HHS Plain Language
Assistant Secretary for Preparedness and Response (ASPR), 200 Independence Ave., SW, Washington, DC 20201
U.S. Department of Health and Human Services | USA.gov |
HealthCare.gov in Other Languages